{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:17:37Z","timestamp":1784265457613,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.dld.2017.12.015","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T07:55:37Z","timestamp":1514447737000},"page":"381-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sorafenib and fluvastatin synergistically alleviate hepatic fibrosis via inhibiting the TGF\u03b21\/Smad3 pathway"],"prefix":"10.1016","volume":"50","author":[{"given":"Yang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WanFu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dld.2017.12.015_bib0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2017.12.015_bib0010","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.dld.2017.12.015_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/egh.10.47","article-title":"Update on the pathophysiology of liver fibrosis","volume":"4","author":"Pinzani","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2017.12.015_bib0020","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1440-1746.1999.01928.x","article-title":"Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy","volume":"14","author":"Li","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2017.12.015_bib0025","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.dld.2017.12.015_bib0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/1319-3767.45072","article-title":"Reversal of liver fibrosis","volume":"15","author":"Ismail","year":"2009","journal-title":"Saudi J Gastroenterol"},{"issue":"19","key":"10.1016\/j.dld.2017.12.015_bib0035","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.dld.2017.12.015_bib0040","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2009.06.024","article-title":"Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats","volume":"51","author":"Reiberger","year":"2009","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2017.12.015_bib0045","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2017.12.015_bib0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/labinvest.2010.148","article-title":"Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis","volume":"91","author":"Hennenberg","year":"2011","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.dld.2017.12.015_bib0055","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/597039","article-title":"Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients","volume":"48","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.dld.2017.12.015_bib0060","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.ejca.2008.06.025","article-title":"Statins and cancer: a systematic review and meta-analysis","volume":"44","author":"Kuoppala","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2017.12.015_bib0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12876-015-0248-8","article-title":"Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells","volume":"15","author":"Chong","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2017.12.015_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.28506","article-title":"Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: results from ERCHIVES","volume":"64","author":"Simon","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2017.12.015_bib0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism","volume":"8","author":"Golomb","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"issue":"14","key":"10.1016\/j.dld.2017.12.015_bib0080","doi-asserted-by":"crossref","first-page":"23265","DOI":"10.18632\/oncotarget.15575","article-title":"Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.dld.2017.12.015_bib0085","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.18632\/oncotarget.6633","article-title":"Protein kinase D2 contributes to TNF-alpha-induced epithelial mesenchymal transition and invasion via the PI3K\/GSK-3beta\/beta-catenin pathway in hepatocellular carcinoma","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"issue":"Pt 2","key":"10.1016\/j.dld.2017.12.015_bib0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/bj2810485","article-title":"A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells","volume":"281","author":"Gandhi","year":"1992","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.dld.2017.12.015_bib0095","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"10.1016\/j.dld.2017.12.015_bib0100","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/jid.2014.75","article-title":"The protective effects of melittin on Propionibacterium acnes-induced inflammatory responses in vitro and in vivo","volume":"134","author":"Lee","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.dld.2017.12.015_bib0105","doi-asserted-by":"crossref","first-page":"18841","DOI":"10.1038\/srep18841","article-title":"Enhancement of hepatocyte differentiation from human embryonic stem cells by Chinese medicine Fuzhenghuayu","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.dld.2017.12.015_bib0110","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9040138","article-title":"Suppression of hepatic epithelial-to-mesenchymal transition by melittin via blocking of TGFbeta\/smad and MAPK-JNK signaling pathways","volume":"9","author":"Park","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"19","key":"10.1016\/j.dld.2017.12.015_bib0115","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N Engl J Med"},{"issue":"46","key":"10.1016\/j.dld.2017.12.015_bib0120","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.3748\/wjg.v12.i46.7413","article-title":"Role of Kupffer cells in the pathogenesis of liver disease","volume":"12","author":"Kolios","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"32","key":"10.1016\/j.dld.2017.12.015_bib0125","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","article-title":"Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition","volume":"282","author":"Zeisberg","year":"2007","journal-title":"J Biol Chem"},{"issue":"1\u20133","key":"10.1016\/j.dld.2017.12.015_bib0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000101322","article-title":"Liver fibrosis: possible involvement of EMT","volume":"185","author":"Ikegami","year":"2007","journal-title":"Cells Tissues Organs"},{"issue":"3","key":"10.1016\/j.dld.2017.12.015_bib0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.23765","article-title":"Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes","volume":"52","author":"Kaimori","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2017.12.015_bib0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2011.02.001","article-title":"Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?","volume":"55","author":"Pinzani","year":"2011","journal-title":"J Hepatol"},{"issue":"30","key":"10.1016\/j.dld.2017.12.015_bib0145","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M700998200","article-title":"Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro","volume":"282","author":"Kaimori","year":"2007","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.dld.2017.12.015_bib0150","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.24254","article-title":"Sorafenib inhibits transforming growth factor beta1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes","volume":"53","author":"Chen","year":"2011","journal-title":"Hepatology"},{"issue":"29","key":"10.1016\/j.dld.2017.12.015_bib0155","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/sj.onc.1207690","article-title":"c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements","volume":"23","author":"Suzuki","year":"2004","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.dld.2017.12.015_bib0160","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1365-2443.2002.00599.x","article-title":"Two major Smad pathways in TGF-beta superfamily signalling","volume":"7","author":"Miyazawa","year":"2002","journal-title":"Genes Cells"},{"issue":"6488","key":"10.1016\/j.dld.2017.12.015_bib0165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/370341a0","article-title":"Mechanism of activation of the TGF-beta receptor","volume":"370","author":"Wrana","year":"1994","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.dld.2017.12.015_bib0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","article-title":"How cells read TGF-beta signals","volume":"1","author":"Massague","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.dld.2017.12.015_bib0175","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00042737-199812000-00009","article-title":"Transforming growth factor betas and their receptors in human liver cirrhosis","volume":"10","author":"Baer","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2017.12.015_bib0180","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis \u2014 from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2017.12.015_bib0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-beta\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"10.1016\/j.dld.2017.12.015_bib0190","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.gastro.2008.04.038","article-title":"Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage","volume":"135","author":"Dooley","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817313324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817313324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T01:53:44Z","timestamp":1535162024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817313324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1590865817313324"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.12.015","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sorafenib and fluvastatin synergistically alleviate hepatic fibrosis via inhibiting the TGF\u03b21\/Smad3 pathway","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}